Cme (CME) Cost of Revenue (2016 - 2026)
Cme has reported Cost of Revenue over the past 18 years, most recently at $52.5 million for Q1 2026.
- Quarterly Cost of Revenue fell 3.31% to $52.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $246.7 million through Mar 2026, down 7.01% year-over-year, with the annual reading at $248.5 million for FY2025, 7.14% down from the prior year.
- Cost of Revenue was $52.5 million for Q1 2026 at Cme, down from $85.9 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $101.9 million in Q4 2023 and troughed at $43.9 million in Q3 2022.
- The 5-year median for Cost of Revenue is $56.6 million (2024), against an average of $63.9 million.
- Biggest five-year swings in Cost of Revenue: rose 28.7% in 2023 and later fell 11.56% in 2025.
- Tracing CME's Cost of Revenue over 5 years: stood at $95.0 million in 2022, then rose by 7.26% to $101.9 million in 2023, then dropped by 11.29% to $90.4 million in 2024, then dropped by 4.98% to $85.9 million in 2025, then plummeted by 38.88% to $52.5 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods came in at $52.5 million, $85.9 million, and $55.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.